| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
| ATP6V1G2-DDX39B |
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
|
0.769 |
0.423 |
| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
| SNHG32 |
|
small nucleolar RNA host gene 32
|
|
2.4E-02 |
0.805 |
0.308 |
| USP8P1 |
|
USP8 pseudogene 1
|
|
|
0.805 |
0.269 |
| PSORS1C3 |
|
psoriasis susceptibility 1 candidate 3
|
|
|
0.769 |
0.269 |
| HCG27 |
|
HLA complex group 27
|
|
2.3E-02 |
0.805 |
0.346 |
| SNORA38 |
|
small nucleolar RNA, H/ACA box 38
|
|
|
0.890 |
0.154 |
| DISC1FP1 |
|
DISC1 fusion partner 1
|
|
|
0.931 |
0.038 |
| LINC02477 |
|
long intergenic non-protein coding RNA 2477
|
|
|
1.000 |
|
| NBPF13P |
|
NBPF member 13, pseudogene
|
|
|
0.890 |
0.038 |
| SLC35F4 |
A4IF30
|
solute carrier family 35 member F4
|
|
8.6E-03 |
0.931 |
0.038 |
| MUC22 |
E2RYF6
|
mucin 22
|
|
1.4E-02 |
0.729 |
0.500 |
| HCG22 |
E2RYF7
|
HLA complex group 22 (gene/pseudogene)
|
|
|
0.736 |
0.423 |
| LST1 |
O00453
|
leukocyte specific transcript 1
|
|
1.1E-03 |
0.792 |
0.308 |
| ABHD16A |
O95870
|
abhydrolase domain containing 16A
|
Enzyme
|
0.47 |
0.861 |
0.269 |
| C6orf47 |
O95873
|
chromosome 6 open reading frame 47
|
|
6.6E-02 |
0.722 |
0.423 |
| TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |